ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin (2020)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkz1213
PubMed Identifier: 31943118
Publication URI: http://europepmc.org/abstract/MED/31943118
Type: Journal Article/Review
Parent Publication: Nucleic Acids Research
Issue: 5
ISSN: 0305-1048